Targeted Strategies for Today's Evolving Markets

MissionIR Blog

BioCryst Pharmaceuticals, Inc. (BCRX) Starts Presentation at the Noble 8th Annual Equity Conference

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) specializes in developing, designing and optimizing novel small-molecule pharmaceuticals to block the key enzymes that play a role in inflammatory diseases, infectious diseases and cancer. BioCryst is currently developing three novel late-stage compounds that treat influenza, gout and cancer. The company continues furthering its discovery of compounds through the use of crystallography and structure-based drug design, also helping others progress through pre-clinical and early development. For further information, visit the company’s Web site at www.BioCryst.com.

Noble Financial, a research driven, full-service investment banking boutique, is as discriminating with its invitations to institutional investors as it is with the companies invited to present. Rather than just focusing on crowding the conference floor, Noble Financial carefully invites a smaller audience of investors with a large appetite for the companies presenting; quality always trumps quantity. For more information or to view webcasts of today’s presentations, visit www.noblefcm.com.

Let us hear your thoughts below:

This entry was posted in Noble Equity Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *